The Star Entertainment Group Ltd (SGR)
Australian Securities Exchange · Australia · prices in AUD · close of 23 Oct 2026
Key indicators
| Last close | AUD 0.120 |
|---|---|
| 52-week range | 0.083 – 0.195 |
| Return, 1 month / 3 months | −20.0% / +0.0% |
| Return, 1 year / 3 years | +30.4% / −80.3% |
| Trend | Below its 200-day average |
| RSI (14) | 42 |
| Volatility (1 year) | 71.5% |
| Worst drawdown (1 year) | -48.9% |
| Average daily value traded | 0.60M AUD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
The Star Entertainment Group is an Australian casino and entertainment company that operates gaming and hospitality complexes in Sydney, Brisbane and the Gold Coast. Its venues offer table games, electronic gaming machines, hotels, restaurants, bars and live entertainment, serving local visitors and tourists. The company is based in Australia and runs its properties under the Star brand, combining casino gaming with dining, accommodation and event facilities for leisure and business guests.
On this site The Star Entertainment Group Ltd appears as a stock on the Australian Securities Exchange (Australia), code SGR, with prices in Australian dollars (AUD). Our dividend records, which start in 2019, show payments in 2 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
The Star Entertainment Group Ltd (SGR) trades on the Australian Securities Exchange in Australia. It last closed at AUD 0.120 on 23 October 2026.
Its price-based Market X-Ray is 71 out of 100 (a strong price profile), ranking 361 of 1,816 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 30.4% and over the last three months it rose 0.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 73 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | -2.5% | ||
| From 52-week high | -33.3% | ||
| Momentum | 79 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 0.0% | ||
| 6-month return | 4.3% | ||
| 12-month return, skipping the last month | 63.0% | ||
| Stability (higher is calmer) | 56 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 71.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -48.9% | ||
| Liquidity | 77 · Strong | Trades actively. | |
| Average daily value traded | 0.60M AUD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +0.0% |
|---|---|
| 1 month | −20.0% |
| 3 months | +0.0% |
| 6 months | +4.3% |
| 1 year | +30.4% |
| 3 years | −80.3% |
| 5 years | −96.6% |
Signals
| 50-day / 200-day average | 0.132 / 0.123 |
|---|---|
| Golden / death cross (60 days) | Golden, 34 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.009 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 25 Feb 2020 | AUD 0.0894 |
| 21 Aug 2019 | AUD 0.0852 |
| 26 Feb 2019 | AUD 0.0894 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.